한글목차

세계 측방 유동 어세이 시장 규모는 2023년 108억 달러에서 예측 기간 동안 7.6%의 연평균 복합 성장률(CAGR)을 나타내고, 2029년에는 168억 달러 규모로 성장할 것으로 예상됩니다.

측방 유동 어세이 시장의 성장은 많은 국가에서 감염성 질환의 확산, 현장 검사에 대한 수요 증가, 가정용 측방 유동 어세이 기기의 사용 증가 등이 배경이 되고 있습니다. 반면, 의사와 환자가 기존 진단 절차의 적용을 꺼리는 점, 측방 유동 어세이의 낮은 정확도 등이 시장 성장의 걸림돌로 작용하고 있습니다.

제품별로 보면, 측방유동 어세이 부문이 가장 빠르게 점유율을 확대하고 있습니다. 측방유동 어세이는 샌드위치법, 경쟁법, 역경쟁법에서 측면 흐름 스트립을 정량적으로 분석할 수 있다는 점에서 높은 점유율을 차지하고 있습니다. 측방유동 어세이는 테스트 라인의 강도를 측정하고 샘플에 존재하는 분석 물질의 수를 결정하여 완전히 정량적인 분석 결과를 얻을 수 있습니다. 측방유동 어세이는 하나의 기기에서 여러 개의 판독값을 얻거나 여러 기기에서 하나의 판독값을 얻을 수 있습니다. 측방유동 어세이는 데이터를 정량화하고 정확하게 수집하고 전송할 수 있습니다. 또한 매우 민감합니다.

지역별로는 아시아태평양이 예측 기간 동안 가장 큰 성장세를 보일 것으로 예상됩니다. 주요 요인으로는 많은 제조업체들이 이 지역에서 제조를 크게 확장하고 있고, 숙련된 인력의 가용성, 저비용 제조 등의 이점이 있기 때문입니다.

세계 측방 유동 어세이(Lateral Flow Assay) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 및 특허 동향, 규제 환경, 사례 연구, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 고객의 비즈니스에 영향을 미치는 동향/파괴적 변화
• 가격 분석
• 에코시스템
• 공급망 분석
• 특허 분석
• 밸류체인 분석
• 기술 분석
• 사례 연구 분석
• 규제 분석
• Porter의 Five Forces 분석
• 인접 시장 분석
• 주요 컨퍼런스 및 이벤트
• 무역 분석
• 업계 동향
• 주요 이해관계자와 구입 기준
• 측방 유동 어세이 시장 : 인플레이션과 불황의 영향
• 측방 유동 어세이 시장에서의 AI
• 미충족 요구/최종사용자의 기대
• 투자/벤처캐피털

제6장 측방 유동 어세이 시장 : 제품별

• 키트 및 시약
• 리더
  • 디지털/핸드헬드 리더
  • 벤치탑 리더
  • 일회용 및 재이용 가능한 측방 유동 어세이리다에 관한 인사이트
  • 임상 진단용 라테라르후로리다 시장 : 유형별

제7장 측방 유동 어세이 시장 : 용도별

• 임상시험
  • 감염증 검사
  • 심장 마커 검사
  • 임신 및 생식 능력 검사
  • 콜레스테롤 및 지질 검사
  • 남용 약물 검사
  • 기타 임상 검사
• 수의 진단
• 식품 안전 및 환경 테스트
• 의약품 개발 및 품질 시험

제8장 측방 유동 어세이킷트 및 시약 시장 : 기술별

• 샌드위치 어세이
• 경쟁 어세이
• 다중 탐지 어세이

제9장 임상 검사용 측방 유동 어세이 시장 : 샘플별

• 혈액
• 소변
• 타액
• 기타

제10장 측방 유동 어세이 시장 : 최종사용자별

• 병원 및 진료소
• 홈케어
• 진단실험실
• 제약 및 바이오테크놀러지 기업
• 기타

제11장 측방 유동 어세이 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제12장 경쟁 구도

• 개요
• 주요 기업의 전략/유력 기업
• 매출 점유율 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 중소기업과 스타트업 기업
• 경쟁 시나리오
• 주요 기업 R&D평가
• 투자 상황
• 평가와 재무 매트릭스

제13장 기업 개요

• 주요 기업
  • ABBOTT LABORATORIES
  • F. HOFFMANN-LA ROCHE LTD.
  • QUIDELORTHO CORPORATION
  • DANAHER CORPORATION
  • SIEMENS AG
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • THERMO FISHER SCIENTIFIC INC.
  • PERKINELMER INC.
  • QIAGEN N.V.
• 기타 기업
  • MERCK KGAA
  • HOLOGIC, INC.
  • ABCAM PLC
  • SURMODICS INC.
  • CHEMBIO DIAGNOSTICS, INC.(BIOSYNEX)
  • ORASURE TECHNOLOGIES
  • DCN DIAGNOSTICS
  • POLYSCIENCES INC.
  • ABINGDON HEALTH
  • ORANOXIS INC.
  • AESKU.GROUP GMBH
  • BIO GROUP MEDICAL SYSTEM S.R.L
  • PHARMACT GMBH
  • DIESSE DIAGNOSTICA SENESE S.P.A.
  • XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.

제14장 부록

영문목차

The lateral flow assays market is valued at an estimated USD 10.8 billion in 2023 and is projected to reach USD 16.8 billion by 2029, at a CAGR of 7.6% during the forecast period. The rising of the lateral flow assay market is because of the high prevalence of infectious diseases in many countries, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices, However the timorousness amongst the doctors and patients to adapt the existing diagnostic procedures and the low accuracy of lateral flow assays are some of the factors which are restraining the market.

"The lateral flow readers segment accounted for the fastest growing share in the lateral flow assays market."

The lateral flow readers is a part of the product segment in lateral flow assays market . Its large share can be attributed to as it enable the quantitative analysis of lateral flow strips in sandwich, competitive,as well as in the reverse-competitive test formats. The lateral flow readers measures the intensity of the test line to determine the. number of analytes present in the sample and yield an assay result that is entirely quantitative. These can also take several readings from a single device or one read from several devices, which is then automatically analyzed statistically to provide a consolidated number. Lateral Flow readers can quantify, precisely collect, and transfer data. They are also very sensitive.

"The urine sample accounted for the second largest segment in the lateral flow assays market."

On the basis of the sample type , the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the second largest market share in 2022. The increasing utilization of the urine samples in lateral flow tests for pregnancy, fertility testing, and drug of abuse testing are some of the factors which attribute to the growth of the segment.

"Asia Pacific market to witness the highest growth during the forecast period."

During the forecast period, APAC is anticipated to grow at the fastest rate. The major factors are as a lot of manufacturers are significantly increasing their manufacturing especially in the Asia Pacific region, which is exhibiting a low-cost manufacturing advantages also the availability of a skilled workforce in these regions. The major factors that are restricting the growth of the market in this region is the lack of awareness about the advantages of near-patient testing products due to lack of reimbursements, challenges related to locational remoteness, and low literacy rates.

A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-20%, and Tier 3-45%
• By Designation: C-level-45%, Director Level-25%, and Others-30%
• By Region: North America-36%, Europe-26%, Asia Pacific-21%, Latin America- 10%, and Middle East and Africa- 7%

Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMerieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).

Research Coverage:

The market study covers the lateral flow assays market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall lateral flow assays market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (High prevalence of infectious diseases, increasing of the geriatric population, Growing use of home-based lateral flow assays devices, Growing demand for point of care testing and need for rapid diagnostic testing for COVID-19), restraints (Inconsistent results of lateral flow analysis), opportunities (evolving application of lateral flow assays, rising demand for lateral flow assays in the food and beverage industries) and challenges limited reimbursements for lateral flow assay products and difficulty in procuring quality raw materials for the development of lateral flow assays tests) influencing the growth of the lateral flow assays market.
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the lateral flow assays market. The report analyzes this market by type of product, application, technique, sample, end-user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the lateral flow assays market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product, application, sample, technique, end-user, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the lateral flow assays market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the lateral flow assays market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION
  • 1.3.2 REGIONS COVERED
  • FIGURE 2 REGIONAL SCOPE
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
  • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • FIGURE 3 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Breakdown of primaries
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
  • FIGURE 7 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2022)
  • FIGURE 8 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2022)
  • FIGURE 9 APPROACH 4: TOP-DOWN APPROACH
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2029): IMPACT ON MARKET GROWTH AND CAGR
  • FIGURE 11 CAGR PROJECTIONS
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
• 2.4 KEY INDUSTRY INSIGHTS
• 2.5 LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
• 2.6 RISK ASSESSMENT
• 2.7 STUDY ASSUMPTIONS
• 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION)
• FIGURE 14 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023 VS. 2029 (USD MILLION)
• FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
• FIGURE 16 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023 VS. 2029 (USD MILLION)
• FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
• FIGURE 18 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
  • FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
• 4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET
  • FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD
• 4.3 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2022)
  • FIGURE 21 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
• 4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
• 4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES
  • FIGURE 23 EMERGING ECONOMIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 High prevalence of infectious diseases
  • TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)
    • 5.2.1.2 Rising geriatric population
  • FIGURE 25 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)
  • FIGURE 26 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)
    • 5.2.1.3 Growing use of home-based lateral flow assay devices
    • 5.2.1.4 Growing demand for POC testing
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Inconsistent results of lateral flow assay tests
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Evolving applications of lateral flow assays
  • TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
    • 5.2.3.2 Rising demand for lateral flow assays in food & beverage industry
    • 5.2.3.3 Emergence of Omicron COVID variant
  • TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT
  • TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE TO DETECT OMICRON
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limited reimbursements for lateral flow assay products
    • 5.2.4.2 Difficulties in procuring quality raw materials to develop tests
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY APPLICATION
  • TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY AND APPLICATION, 2021-2023
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
  • TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2022
• 5.5 ECOSYSTEM
  • TABLE 8 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2022)
• 5.6 SUPPLY CHAIN ANALYSIS
  • 5.6.1 PROMINENT COMPANIES
  • 5.6.2 SMALL & MEDIUM-SIZED COMPANIES
  • 5.6.3 END USERS
• 5.7 PATENT ANALYSIS
  • 5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS
  • FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2013-2023
  • 5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS
  • FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016-2022
  • 5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET
  • FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016-2022
• 5.8 VALUE CHAIN ANALYSIS
  • FIGURE 31 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2022)
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
  • 5.9.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 CASE STUDY 1: QUIDEL LAUNCHES NEW TEST WITH BROADER DETECTION WINDOW
  • 5.10.2 CASE STUDY 2: ABINGTON OFFERS HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
  • 5.10.3 CASE STUDY 3: SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
• 5.11 REGULATORY ANALYSIS
  • 5.11.1 REGULATORY LANDSCAPE
    • 5.11.1.1 North America
    • 5.11.1.2 Europe
    • 5.11.1.3 Asia
      • 5.11.1.3.1 India
      • 5.11.1.3.2 China
      • 5.11.1.3.3 Japan
  • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2.1 North America
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2.2 Europe
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2.3 Asia Pacific
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2.4 Latin America
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2.5 Rest of the world
  • TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 14 LATERAL FLOW ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 ADJACENT MARKET ANALYSIS
  • FIGURE 32 LATERAL FLOW ASSAYS: OVERVIEW OF ADJACENT MARKETS
• 5.14 KEY CONFERENCES AND EVENTS, 2023-2024
  • TABLE 15 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
• 5.15 TRADE ANALYSIS
  • 5.15.1 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
  • TABLE 16 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.15.2 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
  • TABLE 17 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
• 5.16 INDUSTRY TRENDS
  • 5.16.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS
  • TABLE 18 US: HIV PREVALENCE RATE, 2016-2021
  • 5.16.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS
• 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • 5.17.2 BUYING CRITERIA
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
• 5.18 LATERAL FLOW ASSAYS MARKET: IMPACT OF INFLATION AND RECESSION
• 5.19 ARTIFICIAL INTELLIGENCE (AI) IN LATERAL FLOW ASSAY MARKET
  • TABLE 20 POTENTIAL APPLICATIONS OF AI IN LATERAL FLOW ASSAYS
• 5.20 UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 21 LATERAL FLOW ASSAYS MARKET: UNMET NEEDS/END-USER EXPECTATIONS
• 5.21 INVESTMENT/VENTURE CAPITAL
  • FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO, 2018-2022

6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 22 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• 6.2 KITS & REAGENTS
  • 6.2.1 RISING DEMAND FOR POC TESTING TO DRIVE MARKET
  • TABLE 23 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 6.3 READERS
  • TABLE 24 LATERAL FLOW READERS OFFERED, BY COMPANY
  • TABLE 25 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
  • TABLE 26 LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 27 LATERAL FLOW READERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 6.3.1 DIGITAL/HANDHELD READERS
    • 6.3.1.1 Technological evolutions and accuracy to drive adoption
  • TABLE 28 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION).
  • 6.3.2 BENCHTOP READERS
    • 6.3.2.1 Lower diagnosis cost per patient to drive adoption
  • TABLE 29 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 6.3.3 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS
  • 6.3.4 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE
  • TABLE 30 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS
  • FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2022)

7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 31 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• 7.2 CLINICAL TESTING
  • TABLE 32 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 33 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.1 INFECTIOUS DISEASE TESTING
  • TABLE 34 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 35 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.1 Mosquito-borne diseases
      • 7.2.1.1.1 Increasing incidence of dengue to drive market
  • TABLE 36 MAJOR PRODUCTS: DENGUE TESTING
  • TABLE 37 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.2 COVID-19
      • 7.2.1.2.1 Demand for testing to drive market for COVID-19 assays
  • FIGURE 37 NORTH MARKET SIZING FOR COVID-19: SCENARIO-BASED FORECASTING
  • TABLE 38 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS
  • TABLE 39 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.3 Influenza
      • 7.2.1.3.1 Rising prevalence of influenza globally to boost market growth
  • TABLE 40 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.4 Sexually transmitted infections
  • TABLE 41 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 42 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.4.1 HIV
  • TABLE 43 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.4.2 HPV
  • TABLE 44 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.4.3 Chlamydia
  • TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2021-2029
    • 7.2.1.4.4 Gonorrhea
  • TABLE 46 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.4.5 Syphilis
  • TABLE 47 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.4.6 Other sexually transmitted infections
  • TABLE 48 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.5 Hepatitis
      • 7.2.1.5.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
  • TABLE 49 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.6 Tuberculosis
      • 7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market
  • TABLE 50 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.7 Other infectious diseases
  • TABLE 51 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.2 CARDIAC MARKER TESTING
  • TABLE 52 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 53 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.2.1 Troponin I & T
      • 7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market
  • TABLE 54 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.2.2 CK-MB
      • 7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
  • TABLE 55 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.2.3 BNP & NT-proBNP
      • 7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth
  • TABLE 56 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.2.4 Myoglobin
      • 7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
  • TABLE 57 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.2.5 D-Dimer
      • 7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests
  • TABLE 58 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.2.6 Other cardiac marker tests
  • TABLE 59 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.3 PREGNANCY & FERTILITY TESTING
  • TABLE 60 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 61 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.3.1 Pregnancy testing
      • 7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
  • TABLE 62 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.3.2 Fertility testing
      • 7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits
  • TABLE 63 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.4 CHOLESTEROL/LIPID TESTING
    • 7.2.4.1 Lifestyle changes, rising obesity prevalence to drive market
  • TABLE 64 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.5 DRUGS-OF-ABUSE TESTING
    • 7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
  • TABLE 65 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.6 OTHER CLINICAL TESTS
  • TABLE 66 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.3 VETERINARY DIAGNOSTICS
  • 7.3.1 INFECTIOUS DISEASE OUTBREAKS TO DRIVE MARKET
  • TABLE 67 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.4 FOOD SAFETY & ENVIRONMENT TESTING
  • 7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS
  • TABLE 68 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.5 DRUG DEVELOPMENT & QUALITY TESTING
  • 7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
  • TABLE 69 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)

8 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE

• 8.1 INTRODUCTION
  • TABLE 70 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
• 8.2 SANDWICH ASSAYS
  • 8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
  • TABLE 71 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.3 COMPETITIVE ASSAYS
  • 8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
  • TABLE 72 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.4 MULTIPLEX DETECTION ASSAYS
  • 8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET
  • TABLE 73 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)

9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE

• 9.1 INTRODUCTION
  • TABLE 74 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
• 9.2 BLOOD SAMPLES
  • 9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
  • TABLE 75 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)
• 9.3 URINE SAMPLES
  • 9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
  • TABLE 76 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)
• 9.4 SALIVA SAMPLES
  • 9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
  • TABLE 77 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)
• 9.5 OTHER SAMPLES
  • TABLE 78 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)

10 LATERAL FLOW ASSAYS MARKET, BY END USER

• 10.1 INTRODUCTION
  • TABLE 79 LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 10.2 HOSPITALS & CLINICS
  • 10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET
  • TABLE 80 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2029 (USD MILLION)
• 10.3 HOME CARE SETTINGS
  • 10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
  • TABLE 81 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2029 (USD MILLION)
• 10.4 DIAGNOSTIC LABORATORIES
  • 10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
  • TABLE 82 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2029 (USD MILLION)
• 10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
  • TABLE 83 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2029 (USD MILLION)
• 10.6 OTHER END USERS
  • TABLE 84 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2029 (USD MILLION)

11 LATERAL FLOW ASSAYS MARKET, BY REGION

• 11.1 INTRODUCTION
  • FIGURE 38 CHINA TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
  • TABLE 85 LATERAL FLOW ASSAYS MARKET, BY REGION, 2021-2029 (USD MILLION)
• 11.2 NORTH AMERICA
  • TABLE 86 NORTH AMERICA: MACROECONOMIC INDICATORS
  • FIGURE 39 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
  • TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.2.1 NORTH AMERICA: RECESSION IMPACT
  • 11.2.2 US
    • 11.2.2.1 US to hold largest market share of global market, by country
  • TABLE 99 US: MACROECONOMIC INDICATORS
  • TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 101 US: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 102 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 103 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 104 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 105 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 106 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 107 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 108 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 109 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 110 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029USD MILLION)
  • 11.2.3 CANADA
    • 11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market
  • TABLE 111 CANADA: MACROECONOMIC INDICATORS
  • TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 113 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 114 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 115 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 116 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 117 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 118 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 119 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 120 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 121 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 122 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029USD MILLION)
• 11.3 EUROPE
  • 11.3.1 EUROPE: RECESSION IMPACT
  • TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 125 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 126 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 127 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 128 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 130 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 131 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 132 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 133 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.3.2 GERMANY
    • 11.3.2.1 Growing number of POC diagnostics centers to drive demand
  • TABLE 135 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 137 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 138 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 139 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 140 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 141 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 142 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 143 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 144 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 145 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 146 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.3.3 FRANCE
    • 11.3.3.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
  • TABLE 147 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 149 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 150 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 151 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 152 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 153 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 154 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 155 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 156 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 157 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 158 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.3.4 UK
    • 11.3.4.1 Rising prevalence of obesity to propel market
  • TABLE 159 UK: MACROECONOMIC INDICATORS
  • TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 161 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 162 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 163 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 164 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 165 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 166 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 167 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 168 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 169 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 170 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.3.5 ITALY
    • 11.3.5.1 Growing initiatives toward decentralization of medical services to support market growth
  • TABLE 171 ITALY: MACROECONOMIC INDICATORS
  • TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 173 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 174 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 175 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 176 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 177 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 178 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 179 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 180 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 181 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 182 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.3.6 SPAIN
    • 11.3.6.1 Increasing focus of international organizations and domestic players on developing POC products to aid market growth
  • TABLE 183 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 185 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 186 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 187 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 188 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 189 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 190 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 191 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 192 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 193 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 194 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.3.7 REST OF EUROPE
  • TABLE 195 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 196 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 197 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 198 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 199 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 200 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 201 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 202 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 203 REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 204 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 205 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)

• 11.4 ASIA PACIFIC
  • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 40 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
  • TABLE 206 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.4.2 CHINA
    • 11.4.2.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development to drive market
  • TABLE 218 CHINA: MACROECONOMIC INDICATORS
  • TABLE 219 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 220 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 221 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 222 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 223 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 224 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 225 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 226 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 227 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 228 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 229 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.4.3 JAPAN
    • 11.4.3.1 Increasing prevalence of age-related illnesses to drive market
  • TABLE 230 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 231 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 232 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 233 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 234 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 235 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 236 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 237 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 238 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 239 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 240 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 241 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.4.4 INDIA
    • 11.4.4.1 Growing healthcare concerns and rising income levels to propel market growth
  • TABLE 242 INDIA: MACROECONOMIC INDICATORS
  • TABLE 243 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 244 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 245 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 246 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 247 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 248 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 249 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 250 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 251 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 252 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 253 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Increasing prevalence of infectious diseases, especially influenza, to drive market
  • TABLE 254 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 255 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 256 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 257 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 258 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 259 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 260 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 261 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 262 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 263 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 264 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.4.6 SOUTH KOREA
  • TABLE 265 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 266 SOUTH KOREA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 267 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 268 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 269 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 270 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 271 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 272 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 273 SOUTH KOREA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 274 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 275 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.4.7 REST OF ASIA PACIFIC
  • TABLE 276 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 279 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 280 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 281 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 282 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 283 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 284 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 285 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 286 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 11.5 LATIN AMERICA
  • 11.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 287 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 289 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 290 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 291 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 292 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 293 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 295 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 296 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 297 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 298 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.5.2 BRAZIL
    • 11.5.2.1 High private healthcare expenditure and rising geriatric population to drive market
  • TABLE 299 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 300 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 301 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 302 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 303 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 304 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 305 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 306 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 307 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 308 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 309 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 310 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.5.3 MEXICO
    • 11.5.3.1 High prevalence of obesity and related chronic diseases to propel market
  • TABLE 311 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 312 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 313 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 314 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 315 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 316 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 317 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 318 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 319 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 320 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 321 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 322 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.5.4 ARGENTINA
    • 11.5.4.1 Availability of health insurance to favor market growth
  • TABLE 323 ARGENTINA: MACROECONOMIC INDICATORS
  • TABLE 324 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 325 ARGENTINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 326 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 327 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 328 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 329 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 330 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 331 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 332 ARGENTINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 333 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 334 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.5.5 REST OF LATIN AMERICA
  • TABLE 335 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 336 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 337 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 338 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 339 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 340 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 341 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 342 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 343 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 344 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 345 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TO DRIVE MARKET
  • 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 346 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 347 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 348 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 349 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 350 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 351 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 352 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 353 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 356 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.6.3 GCC COUNTRIES
    • 11.6.3.1 GCC countries: Recession impact
  • TABLE 357 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 358 GCC COUNTRIES: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 359 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 360 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 361 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
  • TABLE 362 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 363 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 364 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 365 GCC COUNTRIES: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
  • TABLE 366 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • TABLE 368 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET
• 12.3 REVENUE SHARE ANALYSIS
  • FIGURE 41 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN PAST FIVE YEARS
• 12.4 MARKET SHARE ANALYSIS
  • FIGURE 42 LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
  • TABLE 369 LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 12.5.1 STARS
  • 12.5.2 PERVASIVE PLAYERS
  • 12.5.3 EMERGING LEADERS
  • 12.5.4 PARTICIPANTS
  • FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • 12.5.5 COMPANY FOOTPRINT
  • FIGURE 44 COMPANY FOOTPRINT (25 COMPANIES)
  • TABLE 370 PRODUCT FOOTPRINT (25 COMPANIES)
  • TABLE 371 TECHNIQUE FOOTPRINT (25 COMPANIES)
  • TABLE 372 APPLICATION FOOTPRINT (25 COMPANIES)
  • TABLE 373 SAMPLE TYPE FOOTPRINT (25 COMPANIES)
  • TABLE 374 END-USER FOOTPRINT (25 COMPANIES)
  • TABLE 375 REGIONAL FOOTPRINT (25 COMPANIES)
• 12.6 COMPANY EVALUATION MATRIX: SMES & STARTUPS
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 DYNAMIC COMPANIES
  • 12.6.3 STARTING BLOCKS
  • 12.6.4 RESPONSIVE COMPANIES
  • FIGURE 45 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
  • 12.6.5 COMPETITIVE BENCHMARKING
  • TABLE 376 LATERAL FLOW ASSAY MARKET: DETAILED LIST OF KEY STARTUP/SMES
  • TABLE 377 LATERAL FLOW ASSAY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
• 12.7 COMPETITIVE SCENARIO
  • 12.7.1 PRODUCT LAUNCHES & APPROVALS
  • TABLE 378 LATERAL FLOW ASSAYS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-DECEMBER 2023
  • 12.7.2 DEALS
  • TABLE 379 LATERAL FLOW ASSAYS MARKET: DEALS, JANUARY 2020-DECEMBER 2023
  • 12.7.3 EXPANSIONS
  • TABLE 380 LATERAL FLOW ASSAYS MARKET: EXPANSIONS (JANUARY 2020-DECEMBER 2023)
  • 12.7.4 OTHER DEVELOPMENTS
  • TABLE 381 LATERAL FLOW ASSAYS MARKET: OTHER DEVELOPMENTS, JANUARY 2020-DECEMBER 2023
• 12.8 R&D ASSESSMENT OF KEY PLAYERS
  • FIGURE 46 R&D EXPENDITURE: MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2021 VS. 2022
• 12.9 INVESTMENT LANDSCAPE
  • FIGURE 47 LATERAL FLOW ASSAY MARKET FUNDING SOARED IN 2022
  • FIGURE 48 MOST VALUED LATERAL FLOW ASSAY FIRMS IN 2022 (USD BILLION)
• 12.10 VALUATION AND FINANCIAL MATRICES
  • FIGURE 49 LATERAL FLOW ASSAYS MARKET: VALUATION AND FINANCIAL MATRICES

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 13.1.1 ABBOTT LABORATORIES
• TABLE 382 ABBOTT LABORATORIES: COMPANY OVERVIEW
• FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
• TABLE 383 ABBOTT LABORATORIES: PRODUCTS OFFERED
• TABLE 384 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 385 ABBOTT LABORATORIES: DEALS (JANUARY 2020-DECEMBER 2023)
• 13.1.2 F. HOFFMANN-LA ROCHE LTD.
• TABLE 386 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
• FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
• TABLE 387 F. HOFFMAN-LA ROCHE: PRODUCTS OFFERED
• TABLE 388 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 389 F. HOFFMAN-LA ROCHE: DEALS (JANUARY 2020-DECEMBER 2023)
• TABLE 390 F. HOFFMAN-LA ROCHE: EXPANSIONS (JANUARY 2020-DECEMBER 2023)
• 13.1.3 QUIDELORTHO CORPORATION
• TABLE 391 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
• FIGURE 52 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
• TABLE 392 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
• TABLE 393 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 394 QUIDELORTHO CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
• 13.1.4 DANAHER CORPORATION
• TABLE 395 DANAHER CORPORATION: COMPANY OVERVIEW
• FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
• TABLE 396 DANAHER CORPORATION: PRODUCTS OFFERED
• TABLE 397 DANAHER CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
• 13.1.5 SIEMENS AG
• TABLE 398 SIEMENS AG: COMPANY OVERVIEW
• FIGURE 54 SIEMENS AG: COMPANY SNAPSHOT (2022)
• TABLE 399 SIEMENS AG: PRODUCTS OFFERED
• TABLE 400 SIEMENS AG: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• 13.1.6 BECTON, DICKINSON AND COMPANY
• TABLE 401 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
• FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
• TABLE 402 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
• TABLE 403 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 404 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020-DECEMBER 2023)
• TABLE 405 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020-DECEMBER 2023)
• 13.1.7 BIOMERIEUX SA
• TABLE 406 BIOMERIEUX SA: COMPANY OVERVIEW
• FIGURE 56 BIOMERIEUX SA: COMPANY SNAPSHOT (2022)
• TABLE 407 BIOMERIEUX SA: PRODUCTS OFFERED
• TABLE 408 BIOMERIEUX SA: DEALS (JANUARY 2020-DECEMBER 2023)
• 13.1.8 THERMO FISHER SCIENTIFIC INC.
• TABLE 409 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
• TABLE 410 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
• TABLE 411 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 412 THERMO FISHER SCIENTIFIC INC.: DEALS (JANUARY 2020-DECEMBER 2023)
• 13.1.9 PERKINELMER INC.
• TABLE 413 PERKINELMER INC.: COMPANY OVERVIEW
• FIGURE 58 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
• TABLE 414 PERKINELMER INC.: PRODUCTS OFFERED
• TABLE 415 PERKINELMER INC.: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
• TABLE 416 PERKINELMER INC.: DEALS (JANUARY 2020-DECEMBER 2023)
• 13.1.10 QIAGEN N.V.
• TABLE 417 QIAGEN N.V.: COMPANY OVERVIEW
• FIGURE 59 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
• TABLE 418 QIAGEN N.V.: PRODUCTS OFFERED
• TABLE 419 QIAGEN N.V.: DEALS (JANUARY 2020-DECEMBER 2023)
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 13.2 OTHER PLAYERS
  • 13.2.1 MERCK KGAA
  • 13.2.2 HOLOGIC, INC.
  • 13.2.3 ABCAM PLC
  • 13.2.4 SURMODICS INC.
  • 13.2.5 CHEMBIO DIAGNOSTICS, INC. (BIOSYNEX)
  • 13.2.6 ORASURE TECHNOLOGIES
  • 13.2.7 DCN DIAGNOSTICS
  • 13.2.8 POLYSCIENCES INC.
  • 13.2.9 ABINGDON HEALTH
  • 13.2.10 ORANOXIS INC.
  • 13.2.11 AESKU.GROUP GMBH
  • 13.2.12 BIO GROUP MEDICAL SYSTEM S.R.L
  • 13.2.13 PHARMACT GMBH
  • 13.2.14 DIESSE DIAGNOSTICA SENESE S.P.A.
  • 13.2.15 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS